TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

114:23-33.
21.80 Jabs DA et al. Fomivirsen for the treatment of cytomegalovirus retinitis. Am J Ophthalmol 2002;133:
552-6.
21.81 Vitravene Study Group. Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in
patients with AIDS. Am J Ophthalmol 2002;133:484-98.
21.82 McCutchan JA. Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect
Dis 1995;20:747-54.
21.83 Anders HJ et al. Ganciclovir and foscarnet efficacy in AIDS related CMV polyradiculopathy. J Infect
1998;36:29-33.
21.84 Anders HJ et al. Cytomegalovirus polyradiculopathy in patients with AIDS. Clin Infect Dis 1998;27:
345-52.
21.85 Said G et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and
pathological study. Ann Neurol 1991;29:139-46.
21.86 Machado CM et al. CMV pneumonia in allogeneic BMT recipients undergoing early treatment or preemptive
ganciclovir therapy. Bone Marrow Transplant 2000;26:413-7.
21.87 Teixeira MG et al. Diagnosis and management of dengue. Br Med J 2009;339:1189-93.
21.88 Morens DM. Dengue fever and dengue hemorrhagic fever. Pediatr Infect Dis J 2009;28:635-6.
21.89 Ligon BL. Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment,
and prevention. Semin Pediatr Infect Dis 2005;16:60-5.
21.90 Halstead SB. Dengue. Lancet 2007;370:1644-52.
21.91 Carroll ID et al. Dengue fever and pregnancy. A review and comment. Travel Med Infect Dis 2007;5:
183-8.
21.92 Gibbons RV. Dengue: an escalating problem. Br Med J 2002;324:1563-6.
21.93 Wilder-Smith A et al. Dengue in travelers. N Engl J Med 2005;353:924-32.
21.94 Nhan NT et al. Acute management of dengue shock syndrome: a randomized, double blind comparison
of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001;32:204-13.
21.95 Ostronoff M et al. Serious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages
of immunoglobulin. Clin Infect Dis 2003;36:1623-4.
21.96 Wang SM et al. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect
Ther 2009;7:735-42.
21.97 Lee TC et al. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J 2009;28:904-10.
21.98 Tattevin P et al. Benefits of management strategy adjustments during an outbreak of enterovirus meningitis
in adults. Scand J Infect Dis 2002;34:359-61.
21.99 Kupila L et al. Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal
fluid, stool and serum specimens. Clin Infect Dis 2005;40:982-7.
21.100 Auwaerter PG. Recent advances in the understanding of mononucleosis: are prospects improved for
treatment or control? Expert Rev Anti Infect Ther 2006;4:1030-49.
21.101 Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician 2004;70:1279-87.
21.102 Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000;343:481-92.
21.103 Okano M et al. Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infections in
immunocompromised patients. Expert Rev Anti Infect Ther 2007;5:403-13.
21.104 Macsween KF et al. Epstein-Barr virus: recent advances. Lancet Infect Dis 2003;3:131-40.
21.105 Tynell E et al. Aciclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter,
double blind, placebo controlled study. J Infect Dis 1996;174:324-31.
21.106 Thompson SK et al. Infectious mononucleosis and corticosteroids. Arch Otolaryngol Head Neck
Surg 2005;131:900-4.
21.107 Bausch DG et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N
Engl J Med 2006;355:909-19.
21.108 Feldmann H. Marburg hemorrhagic fever – the forgotten cousin strikes. N Engl J Med 2006;355:866-
9.
21.109 Bray M et al. Filoviruses: recent advances and future challenges. Expert Rev Anti Infect Ther 2006;
4:917-21.
21.110 Mahanty S et al. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 2004;4:487-98.
21.111 Paragas J et al. Development of treatment strategies to combat Ebola and Marburg viruses. Expert
Rev Anti Infect Ther 2006;4:67-76.
21.112 Leroy EM et al. Fruit bats as reservoirs of Ebola virus. Nature 2005;348:575-6.
21.113 Towner JS et al. Marburg virus infection detected in a common African bat. PLoS ONE 2007;2:e764.
21.114 Solomon T. Flavivirus encephalitis. N Engl J Med 2004;351:370-8.
21.115 Gould EA et al. Pathogenic flaviviruses. Lancet 2008;371:500-9.
21.116 Erlanger TE et al. Past, present, and future of Japanese encephalitis. Emerg Infect Dis 2009;15:1-7.
21.117 Romer JR et al. Powassan encephalitis and Colorado tick fever. Infect Dis Clin North Am 2008;22:
545-59.
21.118 Arnež M et al. Tick-borne encephalitis in children: an update on epidemiology and diagnosis. Expert
Rev Anti Infect Ther 2009;7:1251-60.
21.119 Lindquist L et al. Tick-borne encephalitis. Lancet 2008;371:1861-71.
21.120 Kaiser R. Tick-borne encephalitis. Infect Dis Clin North Am 2008;22:561-75.
21.121 Jeong SH et al. Hepatitis A: clinical manifestations and management. Intervirology 2010;53:15-9.
21.122 Koziel MJ et al. Viral hepatitis in HIV infection. N Engl J Med 2007;356:1445-54.
21.123 Gaglio PJ et al. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and
recommendations for therapy. Clin Infect Dis 2007;45:618-23.
21.124 Miailhes P et al. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis
B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV
surface and early antigen seroconversion. Clin Infect Dis 2007;45:624-32.
21.125 Tillmann HL. Screening for and treating hepatitis B virus in patients with HIV infection. Clin Infect Dis
2007;45:633-6.
21.126 Lacombe K et al. HIV/hepatitis B virus co-infection: current challenges and new strategies. J Antimicrob
Chemother 2010;65:10-7.
21.127 Núñez M et al. Management of patients co-infected with hepatitis B virus and HIV. Lancet Infect Dis
2005;5:374-82.
21.128 Thio CL et al, Thomas DL. Treatment of chronic hepatitis B in HIV infected persons: thinking outside
the black box. Clin Infect Dis 2005;41:1035-40.
21.129 Shire NJ et al. Management of HBV/HIV co-infected patients. Semin Liver Dis 2005;25(suppl. 1):48-
57.